{"id":52902,"date":"2023-01-13T15:02:17","date_gmt":"2023-01-13T14:02:17","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/nystrom-associates-names-experienced-behavioral-health-leader-mark-peterson-ceo\/"},"modified":"2023-01-13T15:02:17","modified_gmt":"2023-01-13T14:02:17","slug":"nystrom-associates-names-experienced-behavioral-health-leader-mark-peterson-ceo","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/nystrom-associates-names-experienced-behavioral-health-leader-mark-peterson-ceo\/","title":{"rendered":"Nystrom &amp; Associates Names Experienced Behavioral Health Leader, Mark Peterson, CEO"},"content":{"rendered":"<div>\n<p>MINNEAPOLIS&#8211;(BUSINESS WIRE)&#8211;Nystrom &amp; Associates (\u201cNystrom\u201d) today announced Mark Peterson, RPh, as its new CEO. Peterson succeeds Mark Arnold who has held the role since May of 2020.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230113005253\/en\/1685486\/4\/nystrom.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230113005253\/en\/1685486\/21\/nystrom.jpg\"><\/a><\/p>\n<p>\nDuring Arnold\u2019s tenure, the organization significantly expanded and now provides clinical services in Minnesota, Wisconsin, and Iowa, and will soon add North Dakota. The company also employs over 1,000 behavioral health providers with broad clinical expertise across its 50 outpatient clinics.\n<\/p>\n<p>\n\u201cOn behalf of the Board of Directors, I would like to sincerely thank Mark Arnold for his leadership and commitment to Nystrom\u2019s mission over the past three years,\u201d said Keith Farrow, Managing Director, Nautic Partners LLC. \u201cThe organization now operates in three states, providing exceptional care to meaningfully more consumers than it did when Mark joined.\u201d\n<\/p>\n<p>\nPeterson brings a wealth of experience to the CEO role. He has a long-standing relationship with Nystrom, most recently serving as chairman of its Board of Directors. Prior to that, he was CEO of Genoa Healthcare, an organization that has partnered with Nystrom for over 13 years to provide behavioral health pharmacy services in several of its clinics.\n<\/p>\n<p>\n\u201cWith more than 20 years of experience in behavioral health and an ongoing dedication to the Nystrom organization, we are excited that Mark will lead the company in its next chapter of growth and expansion,\u201d said Brian Nystrom, M.S.W., founder and current board member of Nystrom.\n<\/p>\n<p>\n\u201cAs a founder of Genoa, Mark built a mission-driven organization serving those living with behavioral health issues,\u201d Nystrom said. \u201cHe understands and appreciates the mission, and we are pleased to have him lead Nystrom as it continues to develop.\u201d\n<\/p>\n<p>\nWhile at Genoa, Peterson grew the business from a startup to an industry leader generating over $3 billion in revenue. Throughout that period, the company delivered high quality clinical services and improved the lives of individuals with mental health and substance use disorders. During his tenure, the organization also achieved a medication adherence rate of over 90%, demonstrating a commitment to quality of care, and achieved industry-leading consumer satisfaction. Peterson also broadened Genoa\u2019s service offering, adding telepsychiatry in 2015. Prior to the pandemic, Genoa operated the largest outpatient telepsychiatry business in the country.\n<\/p>\n<p>\n\u201cMark\u2019s commitment to investing in the people of the organization and making Nystrom the employer of choice has been evident since he joined the board. He is a compassionate leader with experience running a high touch and impactful healthcare organization,\u201d said John Figueroa, current Nystrom board member.\n<\/p>\n<p>\n<b>About Nystrom &amp; Associates<\/b>\n<\/p>\n<p>\nNystrom &amp; Associates is a group of professional care providers from the fields of psychiatry, psychology, clinical social work, marriage and family therapy, substance use disorder, and nursing. With about 1,200 employees in 50 clinic locations in Minnesota, Iowa and Wisconsin, Nystrom provides care to individuals and families struggling with personal, emotional, marital, or psychological problems. Nystrom also offers tele-behavioral health and addiction services: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.nystromcounseling.com&amp;esheet=53212075&amp;newsitemid=20230113005253&amp;lan=en-US&amp;anchor=www.nystromcounseling.com&amp;index=1&amp;md5=9b75fc126346c1e40aaa7e01e8cf15f7\" rel=\"nofollow noopener\" shape=\"rect\"><b>www.nystromcounseling.com<\/b><\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nShannon Beaudin Klein<br \/>\n<br \/>612-719-9718\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>MINNEAPOLIS&#8211;(BUSINESS WIRE)&#8211;Nystrom &amp; Associates (\u201cNystrom\u201d) today announced Mark Peterson, RPh, as its new CEO. Peterson succeeds Mark Arnold who has held the role since May of 2020. During Arnold\u2019s tenure, the organization significantly expanded and now provides clinical services in Minnesota, Wisconsin, and Iowa, and will soon add North Dakota. The company also employs over &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/nystrom-associates-names-experienced-behavioral-health-leader-mark-peterson-ceo\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-52902","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nystrom &amp; Associates Names Experienced Behavioral Health Leader, Mark Peterson, CEO - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/nystrom-associates-names-experienced-behavioral-health-leader-mark-peterson-ceo\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nystrom &amp; Associates Names Experienced Behavioral Health Leader, Mark Peterson, CEO - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"MINNEAPOLIS&#8211;(BUSINESS WIRE)&#8211;Nystrom &amp; Associates (\u201cNystrom\u201d) today announced Mark Peterson, RPh, as its new CEO. Peterson succeeds Mark Arnold who has held the role since May of 2020. During Arnold\u2019s tenure, the organization significantly expanded and now provides clinical services in Minnesota, Wisconsin, and Iowa, and will soon add North Dakota. The company also employs over ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/nystrom-associates-names-experienced-behavioral-health-leader-mark-peterson-ceo\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-13T14:02:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230113005253\/en\/1685486\/21\/nystrom.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nystrom-associates-names-experienced-behavioral-health-leader-mark-peterson-ceo\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nystrom-associates-names-experienced-behavioral-health-leader-mark-peterson-ceo\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Nystrom &amp; Associates Names Experienced Behavioral Health Leader, Mark Peterson, CEO\",\"datePublished\":\"2023-01-13T14:02:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nystrom-associates-names-experienced-behavioral-health-leader-mark-peterson-ceo\\\/\"},\"wordCount\":493,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nystrom-associates-names-experienced-behavioral-health-leader-mark-peterson-ceo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230113005253\\\/en\\\/1685486\\\/21\\\/nystrom.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nystrom-associates-names-experienced-behavioral-health-leader-mark-peterson-ceo\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nystrom-associates-names-experienced-behavioral-health-leader-mark-peterson-ceo\\\/\",\"name\":\"Nystrom &amp; Associates Names Experienced Behavioral Health Leader, Mark Peterson, CEO - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nystrom-associates-names-experienced-behavioral-health-leader-mark-peterson-ceo\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nystrom-associates-names-experienced-behavioral-health-leader-mark-peterson-ceo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230113005253\\\/en\\\/1685486\\\/21\\\/nystrom.jpg\",\"datePublished\":\"2023-01-13T14:02:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nystrom-associates-names-experienced-behavioral-health-leader-mark-peterson-ceo\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nystrom-associates-names-experienced-behavioral-health-leader-mark-peterson-ceo\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nystrom-associates-names-experienced-behavioral-health-leader-mark-peterson-ceo\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230113005253\\\/en\\\/1685486\\\/21\\\/nystrom.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230113005253\\\/en\\\/1685486\\\/21\\\/nystrom.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nystrom-associates-names-experienced-behavioral-health-leader-mark-peterson-ceo\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nystrom &amp; Associates Names Experienced Behavioral Health Leader, Mark Peterson, CEO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nystrom &amp; Associates Names Experienced Behavioral Health Leader, Mark Peterson, CEO - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/nystrom-associates-names-experienced-behavioral-health-leader-mark-peterson-ceo\/","og_locale":"en_US","og_type":"article","og_title":"Nystrom &amp; Associates Names Experienced Behavioral Health Leader, Mark Peterson, CEO - Pharma Trend","og_description":"MINNEAPOLIS&#8211;(BUSINESS WIRE)&#8211;Nystrom &amp; Associates (\u201cNystrom\u201d) today announced Mark Peterson, RPh, as its new CEO. Peterson succeeds Mark Arnold who has held the role since May of 2020. During Arnold\u2019s tenure, the organization significantly expanded and now provides clinical services in Minnesota, Wisconsin, and Iowa, and will soon add North Dakota. The company also employs over ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/nystrom-associates-names-experienced-behavioral-health-leader-mark-peterson-ceo\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-13T14:02:17+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230113005253\/en\/1685486\/21\/nystrom.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/nystrom-associates-names-experienced-behavioral-health-leader-mark-peterson-ceo\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/nystrom-associates-names-experienced-behavioral-health-leader-mark-peterson-ceo\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Nystrom &amp; Associates Names Experienced Behavioral Health Leader, Mark Peterson, CEO","datePublished":"2023-01-13T14:02:17+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/nystrom-associates-names-experienced-behavioral-health-leader-mark-peterson-ceo\/"},"wordCount":493,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/nystrom-associates-names-experienced-behavioral-health-leader-mark-peterson-ceo\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230113005253\/en\/1685486\/21\/nystrom.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/nystrom-associates-names-experienced-behavioral-health-leader-mark-peterson-ceo\/","url":"https:\/\/pharma-trend.com\/en\/nystrom-associates-names-experienced-behavioral-health-leader-mark-peterson-ceo\/","name":"Nystrom &amp; Associates Names Experienced Behavioral Health Leader, Mark Peterson, CEO - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/nystrom-associates-names-experienced-behavioral-health-leader-mark-peterson-ceo\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/nystrom-associates-names-experienced-behavioral-health-leader-mark-peterson-ceo\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230113005253\/en\/1685486\/21\/nystrom.jpg","datePublished":"2023-01-13T14:02:17+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/nystrom-associates-names-experienced-behavioral-health-leader-mark-peterson-ceo\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/nystrom-associates-names-experienced-behavioral-health-leader-mark-peterson-ceo\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/nystrom-associates-names-experienced-behavioral-health-leader-mark-peterson-ceo\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230113005253\/en\/1685486\/21\/nystrom.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230113005253\/en\/1685486\/21\/nystrom.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/nystrom-associates-names-experienced-behavioral-health-leader-mark-peterson-ceo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Nystrom &amp; Associates Names Experienced Behavioral Health Leader, Mark Peterson, CEO"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52902","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=52902"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52902\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=52902"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=52902"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=52902"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}